Carregant...
Recent knowledge in favor of remdesivir (GS-5734) as a therapeutic option for the COVID-19 infections
The management of SARS-CoV-2 has not yet been clearly determined and is based on potential therapies evaluated during the SARS-CoV and MERS-CoV outbreaks. An emerging potential therapeutic approach currently being evaluated in numerous clinical trials is the remdesivir agent, which acts on COVID-19...
Guardat en:
| Publicat a: | J Infect Public Health |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8039503/ https://ncbi.nlm.nih.gov/pubmed/33857725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiph.2021.02.006 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|